SPHK1 and Huntington disease: Coherently, stimulation of SPHK1, by the selective pharmacological activator K6PC-5 (Ji et al., 2015), significantly reduces apoptosis in mouse striatal derived HD cell lines and leads to the activation of pro-survival signaling pathways (Di Pardo et al., 2017a).